'Fast track' or 'conditional marketing approval' for EFTI would be a given when (if) AIPAC p2b results are good/great H2 2019.
Next presentation cab of the rank is 761 tomorrow in Copenhagen (6pm Copenhagen time. Wonderful.). I assume this will be officially released to ASX pre-open tomorrow?
Poster up on 'ECCO' web site. Could be the old 'left, right' combination.....
DOP07: IMP761, a novel anti-LAG-3 agonist antibody for the treatment of auto-immune diseases
M. Angin, C. Brignone, F. Triebel
Immutep, Orsay, France
Ann: TACTI-mel data presented at World Immunotherapy Congress, page-24
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
30.5¢ |
Change
0.020(7.02%) |
Mkt cap ! $486.6M | |||
| Open | High | Low | Value | Volume |
| 29.0¢ | 31.0¢ | 29.0¢ | $1.171M | 3.900M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 101067 | 30.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 31.0¢ | 8068 | 2 |
View Market Depth
| Last trade - 16.10pm 22/11/2024 (20 minute delay) ? |
| IMM (ASX) Chart |
